The state of Nevada is eager for its upcoming 2016 general
election ballot initiative that proposes legalizing recreational use of
marijuana. Using Colorado’s $700 million intake last year as a reference point,
it sees the state trending to break $1 billion in annual revenues by 2016. With
this data, projections from the state Department of Revenue tell us the MMJ
market in Nevada could easily get a lot bigger in the months ahead.
GrowBLOX Sciences, Inc. focuses on the research and
development of medical cannabis drugs and treatments. Producer of medical-grade
cannabis, cannabis concentrates, and cannabinoid therapies through using
various technologies in plant biology, cultivation, and extraction techniques
combined with biotechnology, the company is involved in the development of
controlled-climate indoor agricultural technology growing and cultivation
suites.
In the GBLX Drug Development Ecosystem, the company holds
the patents and coordinates the research data from all of its research
partners. Partner data is pulled together and partners are realize incentives
with equity in relative to the value of the data they contribute. Bonus equity
can be rewarded retroactively when data previously contributed becomes a part
of a patent, IND filing, or NDA filing. The company finds that the equity
incentive system increases efficiency and productivity in drug discovery.
Further the company encourages real and virtual collaboration among the
researchers in the ecosystem.
GB Sciences fills the discovery role in the ecosystem. Other
members of the GBLX Drug Development Ecosystem include universities, small and
medium biotechnology companies and clinical research organizations (CRO).
Preclinical research comes by way of its University partners. Clinical trials
are run by Clinical Research Organization (CRO) partners and can be licensed to
Pharmaceutical Licensees before the Human Phase III trials. Distribution is
through specialty pharmaceutical channels, including hospitals and research
centers.
GrowBLOX Sciences combines state-of-the-art technologies in
plant biology, cultivation and post-production processes to optimize safe
medical Cannabis. The company is pioneering technologies and industry-leading
processes in combination with a Big Data-driven clinical research and
development program to bring relief to patients all over the United States.
To learn more about the company visit www.growblox.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment